Jeffrey Mitchell

Board-facing Chief Financial Officer with 30+ years of experience leading capital strategy across public, private equity-backed, venture-backed, and federally funded enterprises. Proven in scaling organizations through commercialization, strategic transactions, and operational expansion. Drive disciplined capital allocation, liquidity management, and margin growth while strengthening governance and investor confidence.

Translate financial complexity into clear strategy that aligns execution with durable enterprise value creation.

I am a board-facing Chief Financial Officer with more than 30 years of experience leading financial strategy across public, venture-backed, private equity-backed, and federally funded organizations. I have extensive expertise in capital markets, operational scaling, and strategic transactions, including raising over $40M in financing, driving significant margin expansion, and supporting major corporate exits. Currently I am serving as Deputy CFO at MIT Lincoln Laboratory, I oversees financial strategy for a $1.5B operating portfolio while maintaining full audit compliance and leading enterprise financial systems transformation.

Previously, as CFO of LexaGene, I built the finance function from inception, managed public company reporting, and led capital strategy through commercialization. Earlier in my career at Palomar Medical Technologies, I helped scale revenue from $15M to $150M and supported a $300M strategic sale, while managing global finance operations and SEC compliance.

Master’s Degree - Finance

University of Wisconsin - Whitewater

2002